Pacific Biosciences
PACB
PACB
227 hedge funds and large institutions have $332M invested in Pacific Biosciences in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
-39
Holders Change %
-14.66%
% of All Funds
3.3%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
35
Increased
81
Reduced
60
Closed
71
Calls
$2.38M
Puts
$3M
Net Calls
-$620K
Net Calls Change
-$1.98M
Top Buyers
| 1 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$8.53M |
| 2 |
MA
Madrone Advisors
Menlo Park,
California
|
+$7.95M |
| 3 |
Millennium Management
New York
|
+$3.04M |
| 4 |
Goldman Sachs
New York
|
+$2.43M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$2.33M |
